Citation Impact
Citing Papers
Prospective identification of tumorigenic breast cancer cells
2003 Standout
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Facts and Controversies in Systemic Treatment of Metastatic Breast Cancer
2004
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Overexpression of ErbB2 Blocks Taxol-Induced Apoptosis by Upregulation of p21Cip1, which Inhibits p34Cdc2 Kinase
1998
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents
2012
Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
2014
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine
1993
Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer
2000
Characterization of the Taxol Binding Site on the Microtubule
1995
Breast cancer
2016 Standout
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed
2016
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
1996 Standout
Primary Care for Survivors of Breast Cancer
2000
Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide
1991
Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer
1999 Standout
Imaging in the era of molecular oncology
2008 StandoutNature
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
1998
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
1990
Paclitaxel (Taxol)
1995 Standout
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation
2001 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Esophageal Cancer
2003 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the eastern cooperative oncology group
1993
Tumor‐vascular interactions and tumor dormancy
2008
Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients
2014
The Cyclin-Ubiquitin Ligase Activity of Cyclosome/APC Is Jointly Activated by Protein Kinases Cdk1-Cyclin B and Plk
2002 StandoutNobel
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat.
1995
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy
2009
Apoptosis
2002 Standout
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma
2001
EMT: 2016
2016 Standout
Structure of the αβ tubulin dimer by electron crystallography
1998 StandoutNature
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Heterogeneity of breast cancer and implications of adjuvant chemotherapy
2007
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Molecular mechanisms of metastasis in breast cancer—clinical applications
2010
Treatment of Breast Cancer
1998
Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization
1997
Kaposi's Sarcoma
2000 Standout
DNA binding of iproplatin and its divalent metabolitecis-dichloro-bis-isopropylamine platinum(II)
1990
Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.
1995
Angiogenesis as a therapeutic target
2005 StandoutNature
Side Effects of Adjuvant Treatment of Breast Cancer
2001
Preservation of Fertility in Patients with Cancer
2009 Standout
Cancer of the Ovary
2004 Standout
Phase I Trial of Taxol as a Radiation Sensitizer with Cisplatin in Advanced Cervical Cancer
1997
Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma
1999
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
2005
A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: A randomized, double-blind study
1990
Paclitaxel Is Safe and Effective in the Treatment of Advanced AIDS-Related Kaposi's Sarcoma
1999
Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer
2003
Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193)
2003
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer.
2001
Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease.
1999
Electrostatics of nanosystems: Application to microtubules and the ribosome
2001 Standout
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
2008
Extending Survival with Chemotherapy in Metastatic Breast Cancer
2005
Radiation Therapy for Breast Cancer and Increased Risk for Esophageal Carcinoma
1998
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
3'-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of beta-tubulin.
1994
The Traditional Medicine and Modern Medicine from Natural Products
2016 Standout
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
The incidence of secondary leukemias.
1999
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Failure of Higher-Dose Paclitaxel to Improve Outcome in Patients With Metastatic Breast Cancer: Cancer and Leukemia Group B Trial 9342
2004
Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer
2005
Works of D. Frye being referenced
Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers
2007
Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.
1996
Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.
1997
Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma
1989
Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer
1991
Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.
1996
Phase II study of iproplatin in metastatic breast carcinoma.
1987
Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study.
1987